Bertrand Sagnia
Overview
Explore the profile of Bertrand Sagnia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sagnia B, Mbakop Ghomsi F, Moudourou S, Gutierez A, Tchadji J, Sosso S, et al.
PLoS One
. 2024 Mar;
19(3):e0297790.
PMID: 38507344
Background: Measurements of CD4 T cells and hemoglobin (Hb) are conventionally used to determine the immunological state and disease progression for HIV-infected patients. We obtained a small lightweight point-of-care device,...
2.
Kae A, Santoro M, Nanfack A, Ngoufack Jagni Semengue E, Yagai B, Nka A, et al.
J Pediatr
. 2024 Jan;
267:113919.
PMID: 38237889
Objective: To conduct a comprehensive, systematic review of the profile of HIV-1 reservoirs in children and adolescents with perinatally acquired HIV infection. Study Design: Randomized and nonrandomized trials, cohort studies,...
3.
Kae A, Nanfack A, Santoro M, Yagai B, Ambada G, Sagnia B, et al.
BMJ Open
. 2023 Oct;
13(10):e073672.
PMID: 37816567
Introduction: The success of antiretroviral therapy (ART) has changed HIV from a deadly to a chronic infection, thus increasing the transitioning from infancy toward adulthood. However, the virostatic nature of...
4.
Nanfack A, Ndzengue G, Fokam J, Kae A, Sonela N, Kenou L, et al.
JMIR Res Protoc
. 2022 Nov;
11(11):e41473.
PMID: 36449339
Background: Antiretroviral therapy (ART) can bring HIV-1 levels in blood plasma to the undetectable level and allow a near-normal life expectancy for HIV-infected individuals. Unfortunately, ART is not curative and...
5.
Sagnia B, Kiazyk S, Meyers A, Plews M, Diallo T, Sosso S, et al.
Sci Rep
. 2021 Jun;
11(1):11536.
PMID: 34078982
Participation in an EQA program is critical to the quality assurance process. Reliable and precise CD4 T-cells enumeration are essential to improve the clinical management of patients by evaluating the...
6.
Sagnia B, Mbakop Ghomsi F, Gutierrez A, Sosso S, Kamgaing R, Nanfack A, et al.
AIDS Res Ther
. 2020 Aug;
17(1):53.
PMID: 32799909
Background: In the context of scaling the viral load in resource limited settings, following HIV infected patient's adults and children with CD4+ T-lymphocyte count still very important in settings where...
7.
Ngu L, Nji N, Ambada G, Ngoh A, Njambe Priso G, Tchadji J, et al.
Immun Inflamm Dis
. 2017 Dec;
6(1):163-175.
PMID: 29205929
Introduction: Recombinant Newcastle Disease virus (rNDV) vectored vaccines are safe mucosal applicable vaccines with intrinsic immune-modulatory properties for the induction of efficient immunity. Like all viral vectored vaccines repeated inoculation...
8.
Ngu L, Nji N, Ambada G, Sagnia B, Sake C, Tchadji J, et al.
Immun Inflamm Dis
. 2017 May;
7(2):55-67.
PMID: 28474788
Introduction: Targeting antigens to dendritic cells (DCs) in vivo via a DC-restricted endocytic receptor, DEC205, has been validated to enhance immunity in several vaccine platforms. Particularly atttractive is selected delivery...
9.
Sagnia B, Fedeli D, Casetti R, Montesano C, Falcioni G, Colizzi V
PLoS One
. 2014 Aug;
9(8):e103999.
PMID: 25090613
Background: The vast majority of the population around the world has always used medicinal plants as first source of health care to fight infectious and non infectious diseases. Most of...
10.
Cairo C, Longinaker N, Cappelli G, Leke R, Ondo M, Djokam R, et al.
J Infect Dis
. 2013 Dec;
209(10):1653-62.
PMID: 24325967
Background: Plasmodium falciparum placental infection primes the fetal immune system and alters infant immunity. Mechanisms leading to these outcomes are not completely understood. We focused on Vγ2Vδ2 cells, which are...